Global Artificial Insemination Market 2018-2022
SKU ID : TNV-12378426 | Publishing Date : 03-May-2018 | No. of pages : 116
Detailed TOC of Global Artificial Insemination Market 2018-2022
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Commercial users– Market size and forecast 2017-2022
• Individual users– Market size and forecast 2017-2022
• Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Rising cases of prostate cancer
• Growing online retail sales of home insemination kits
• Rising number of sperm donors at sperm banks
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Church & Dwight
• INVO Bioscience
• Piramal Enterprises
• Rinovum Women's Health
• The Cooper Companies
• Vitrolife
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Parent market
Exhibit 02: Global infertility treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017-2022
Exhibit 18: Customer landscape
Exhibit 19: Global artificial insemination market – Market share by end-users 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Commercial users – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Commercial users – Year over year growth 2018-2022 (%)
Exhibit 23: Individual users – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Individual users – Year over year growth 2018-2022 (%)
Exhibit 25: Market opportunity by end-user
Exhibit 26: Global artificial insemination market – Market share by geography 2017-2022 (%)
Exhibit 27: Regional comparison
Exhibit 28: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Americas – Year over year growth 2018-2022 (%)
Exhibit 30: Top 3 countries in Americas
Exhibit 31: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: EMEA – Year over year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in EMEA
Exhibit 34: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: APAC – Year over year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in APAC
Exhibit 37: Market opportunity
Exhibit 38: Global hubs for fertility tourism
Exhibit 39: Estimated cancer cases and deaths in US 2017
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Church & Dwight overview
Exhibit 46: Church & Dwight – Business segments
Exhibit 47: Church & Dwight – Organizational developments
Exhibit 48: Church & Dwight – Geographic focus
Exhibit 49: Church & Dwight – Segment focus
Exhibit 50: Church & Dwight – Key offerings
Exhibit 51: INVO Bioscience overview
Exhibit 52: INVO Bioscience– Business segments
Exhibit 53: INVO Bioscience– Organizational developments
Exhibit 54: INVO Bioscience– Geographic focus
Exhibit 55: INVO Bioscience– Segment focus
Exhibit 56: INVO Bioscience– Key offerings
Exhibit 57: Piramal Enterprises overview
Exhibit 58: Piramal Enterprises– Business segments
Exhibit 59: Piramal Enterprises– Organizational developments
Exhibit 60: Piramal Enterprises– Geographic focus
Exhibit 61: Piramal Enterprises– Segment focus
Exhibit 62: Piramal Enterprises– Key offerings
Exhibit 63: Rinovum Women's Health overview
Exhibit 64: Rinovum Women's Health– Business segments
Exhibit 65: Rinovum Women's Health– Organizational developments
Exhibit 66: Rinovum Women's Health– Geographic focus
Exhibit 67: Rinovum Women's Health– Segment focus
Exhibit 68: Rinovum Women's Health– Key offerings
Exhibit 69: Vendor overview
Exhibit 70: The Cooper Companies– Business segments
Exhibit 71: The Cooper Companies– Organizational developments
Exhibit 72: The Cooper Companies– Geographic focus
Exhibit 73: The Cooper Companies– Segment focus
Exhibit 74: The Cooper Companies– Key offerings
Exhibit 75: Vendor overview
Exhibit 76: Vitrolife – Business segments
Exhibit 77: Vitrolife – Organizational developments
Exhibit 78: Vitrolife – Geographic focus
Exhibit 79: Vitrolife – Segment focus
Exhibit 80: Vitrolife – Key offerings
Keyplayers in Global Artificial Insemination Market 2018-2022
Church & DwightINVO Bioscience
Piramal Enterprises
Rinovum Women's Health
The Cooper Companies
Vitrolife